NEPTUNUS-1 and 2: Monthly Ianalumab Significantly Improves Sjögren Disease ActivityByVictoria JohnsonNovember 4th 2025
Telitacicept Improves Sjögren Symptoms Over Placebo in Phase 3 TrialByVictoria JohnsonOctober 25th 2025
Cutaneous Vasculitis Subtype Associated With Poor Outcomes in Sjögren DiseaseByVictoria JohnsonAugust 13th 2025
Ghaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’sByVictoria JohnsonNovember 20th 2024